Nicholaos Bellos

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin et al. · New England Journal of Medicine · 2008 · 359 citations

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

Kimberly Y. Smith, Parul Patel, Derek M. Fine et al. · AIDS · 2009 · 217 citations

Tenofovir Disoproxil Fumarate in Nucleoside-Resistant HIV-1 Infection

Kathleen Squires, Anton Pozniak, Gerald Pierone et al. · Annals of Internal Medicine · 2003 · 199 citations

SOLO

Joseph Gathe, Prudence Ive, Robin Wood et al. · AIDS · 2004 · 196 citations

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

Jean‐Michel Molina, Kathleen Squires, Paul E. Sax et al. · The Lancet HIV · 2018 · 140 citations

Treatment And Prevention, Antiviral Drug Development, Clinical Trials +7